CCM
TMDX icon

Cadence Capital Management’s Transmedics TMDX Stock Holding History

Cadence Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$221K Buy
+16,024
New +$275K 0.05% 267

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Cadence Capital Management's TMDX Position: Q3 2020 in Review

Cadence Capital Management opened a new position in Transmedics (TMDX) in Q3 2020: 16,024 shares worth $221K. The stake represents 0.05% of the portfolio and ranks #267 among its holdings.

73 funds tracked by Wall St. Rank hold TMDX as of Q3 2020.

  • Cadence Capital Management held 16,024 shares of Transmedics worth $221K as of Q3 2020.
  • Transmedics was a new Cadence Capital Management position in Q3 2020.
  • Transmedics made up 0.05% of Cadence Capital Management's portfolio in Q3 2020, its #267 holding.
  • 73 funds tracked by Wall St. Rank held Transmedics as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.